Literature DB >> 34669610

Understanding Penicillin Allergy, Cross-reactivity, and Antibiotic Selection in the Preoperative Setting.

Shumaila Sarfani1, Cosby A Stone, G Andrew Murphy, David R Richardson.   

Abstract

Penicillin allergies are reported by 8% to 15% of the US population, but up to 95% of these allergies do not correspond to a true allergy when tested. Recent studies have demonstrated that having a penicillin allergy label (PAL) results in a 50% increased odds of surgical site infection among patients reporting a penicillin allergy entirely attributable to the use of a beta-lactam alternative antibiotic (primarily clindamycin or vancomycin). This study provides a review of the prevalence of PAL, the cross-reactivity with cefazolin, immunogenic components of cefazolin and penicillin, and current guidelines for preoperative antibiotic selection in patients with PALs. On understanding these principles, a new set of guidelines and a risk stratification tool are proposed for assessing allergies and determining appropriate antibiotic choice, dosage, and timing in the orthopaedic preoperative setting.
Copyright © 2021 by the American Academy of Orthopaedic Surgeons.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34669610      PMCID: PMC8928301          DOI: 10.5435/JAAOS-D-21-00422

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  34 in total

1.  Penicillin allergy and the cephalosporins.

Authors:  C H Dash
Journal:  J Antimicrob Chemother       Date:  1975       Impact factor: 5.790

2.  Drug allergy: an updated practice parameter.

Authors: 
Journal:  Ann Allergy Asthma Immunol       Date:  2010-10       Impact factor: 6.347

3.  Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals.

Authors:  Jennifer S McDanel; Eli N Perencevich; Daniel J Diekema; Loreen A Herwaldt; Tara C Smith; Elizabeth A Chrischilles; Jeffrey D Dawson; Lan Jiang; Michihiko Goto; Marin L Schweizer
Journal:  Clin Infect Dis       Date:  2015-04-21       Impact factor: 9.079

4.  Reduction of vancomycin use in orthopedic patients with a history of antibiotic allergy.

Authors:  J T Li; P J Markus; D R Osmon; L Estes; V A Gosselin; A D Hanssen
Journal:  Mayo Clin Proc       Date:  2000-09       Impact factor: 7.616

5.  The Cost of Penicillin Allergy Evaluation.

Authors:  Kimberly G Blumenthal; Yu Li; Aleena Banerji; Brian J Yun; Aidan A Long; Rochelle P Walensky
Journal:  J Allergy Clin Immunol Pract       Date:  2017-09-22

6.  The Impact of a Reported Penicillin Allergy on Surgical Site Infection Risk.

Authors:  Kimberly G Blumenthal; Erin E Ryan; Yu Li; Hang Lee; James L Kuhlen; Erica S Shenoy
Journal:  Clin Infect Dis       Date:  2018-01-18       Impact factor: 9.079

Review 7.  The challenge of de-labeling penicillin allergy.

Authors:  Cosby A Stone; Jason Trubiano; David T Coleman; Christine R F Rukasin; Elizabeth J Phillips
Journal:  Allergy       Date:  2019-05-26       Impact factor: 13.146

8.  Natural evolution of skin test sensitivity in patients allergic to beta-lactam antibiotics.

Authors:  M Blanca; M J Torres; J J García; A Romano; C Mayorga; E de Ramon; J M Vega; A Miranda; C Juarez
Journal:  J Allergy Clin Immunol       Date:  1999-05       Impact factor: 10.793

9.  Preoperative Allergy Testing for Patients Reporting Penicillin and Cephalosporin Allergies is Cost-Effective in Preventing Infection after Total Knee and Hip Arthroplasty.

Authors:  Nicholas R Pagani; Michael A Moverman; Richard N Puzzitiello; Mariano E Menendez; C Lowry Barnes; Joseph J Kavolus
Journal:  J Arthroplasty       Date:  2020-08-27       Impact factor: 4.757

Review 10.  Cephalosporin Allergy: Current Understanding and Future Challenges.

Authors:  David A Khan; Aleena Banerji; Jonathan A Bernstein; Basar Bilgicer; Kimberly Blumenthal; Mariana Castells; Daniel Ein; David M Lang; Elizabeth Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2019 Sep - Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.